ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Nutrition Program Starts To Zero In On Mass Of Data, Plan Contract And Grant Project Areas

August 29, 1975

Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups

July 8, 2011

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

Army Breast Cancer Research Program Seeks Proposals

March 28, 1997

New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors

June 29, 2001

New Chemotherapy, Other Modality Progress Described

March 30, 1979